#BCCPA2018 Session: Influenza in Seniors: Helping to Protect a Vulnerable Population
In 2015, a high-dose trivalent influenza vaccine (TIV) was licensed in Canada to provide better protection against what is well recognized as a devastating, frequently debilitating and life-threatening disease. The National Advisory Committee on Immunization (NACI) in their annual Influenza Seasonal Report stated, “The high-dose TIV should provide superior protection compared with the standard dose […]
